As a result, a market for cheaper, off-brand versions of their active ingredients — semaglutide and tirzepatide — has ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Compounded GLP-1s are no longer to be sold following the FDA announcement that the shortage of semaglutide and tirzepatide ended.

The medicines watchdog has issued an urgent warning about a deluge of social media advertisements for counterfeit weight-loss drugs.

HPRA concerned by promotions for ‘made in Ireland’ obesity medications wrongly claiming to be approved by charities, ...

Explore the evolving landscape of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for obesity, highlighting access ...

The HPRA warned that “dubious sites and social media posts” are using the official HPRA logo to falsely claim products are ...

As global shortages hit Ozempic and Wegovy, rivals like Eli Lilly gain ground, including in India’s growing market for ...

Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant ...

Eli Lilly and Company today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro), retatrutide, eloralintide and bimagrumab will be presented at ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...